Tyra Biosciences (TYRA) Net Equity Issued and Repurchased (2021 - 2026)

Tyra Biosciences (TYRA) posted Net Equity Issued and Repurchased of $147.9 million for Q1 2026, up 278.93% on a QoQ basis from -$82.6 million in Q3 2021.

Tyra Biosciences (TYRA) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Tyra Biosciences' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $147.9 million for Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $147.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.9 million (changed N/A YoY) and the FY2021 annual result came in at $23.5 million, up 0.79% from the prior year.
  • Net Equity Issued and Repurchased was $147.9 million for Q1 2026 at Tyra Biosciences, up from -$82.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $147.9 million in Q1 2026 and bottomed at $147.9 million in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Tyra Biosciences 1.90 Bn 1.90 Bn - 147.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 147.85 Mn
Mar 31, 2026 147.85 Mn
Sep 30, 2021 -82.63 Mn
Sep 30, 2021 -82.63 Mn
Jun 30, 2021 28,000.00
Jun 30, 2021 28,000.00
Mar 31, 2021 106.10 Mn
Mar 31, 2021 106.10 Mn